Enanta Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$12.51

-0.49 (-3.77%)

As of Mar 22, 10:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +256.1% upside

Low Target $33.16

Average Target $44.55

High Target $53.28

Current Price $12.51

Current
$12.51

Target
$44.55

$33.16 $44.55 avg $53.28

Scenario Analysis

Bear Case

$33.16

165.1%

Low target

Base Case

$44.55

+256.1%

Avg target

Bull Case

$53.28

+325.9%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$17.15

-27.1% from high

52-Week Low

$4.09

+205.9% from low

Target vs 52W High

$44.55

+159.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%